321 related articles for article (PubMed ID: 23193979)
1. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.
Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J
Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979
[TBL] [Abstract][Full Text] [Related]
2. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.
Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J
CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839
[TBL] [Abstract][Full Text] [Related]
3. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.
Chung S; Ben-Menachem E; Sperling MR; Rosenfeld W; Fountain NB; Benbadis S; Hebert D; Isojärvi J; Doty P
CNS Drugs; 2010 Dec; 24(12):1041-54. PubMed ID: 21090838
[TBL] [Abstract][Full Text] [Related]
4. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
Pasha I; Kamate M; Didagi SK
Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
[TBL] [Abstract][Full Text] [Related]
7. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial.
Zadeh WW; Escartin A; Byrnes W; Tennigkeit F; Borghs S; Li T; Dedeken P; De Backer M;
Seizure; 2015 Sep; 31():72-9. PubMed ID: 26362380
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study.
Toupin JF; Lortie A; Major P; Diadori P; Vanasse M; Rossignol E; D'Anjou G; Perreault S; Larbrisseau A; Carmant L; Birca A
Epileptic Disord; 2015 Dec; 17(4):436-43. PubMed ID: 26609635
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
[TBL] [Abstract][Full Text] [Related]
11. Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy.
Kim JS; Kim H; Lim BC; Chae JH; Choi J; Kim KJ; Hwang YS; Hwang H
Brain Dev; 2014 Jun; 36(6):510-5. PubMed ID: 23948372
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Baulac M; Rosenow F; Toledo M; Terada K; Li T; De Backer M; Werhahn KJ; Brock M
Lancet Neurol; 2017 Jan; 16(1):43-54. PubMed ID: 27889312
[TBL] [Abstract][Full Text] [Related]
15. Lacosamide add-on therapy for partial epilepsy.
Weston J; Shukralla A; McKay AJ; Marson AG
Cochrane Database Syst Rev; 2015 Jun; (6):CD008841. PubMed ID: 26077821
[TBL] [Abstract][Full Text] [Related]
16. [Clinical experience with lacosamide in Galicia: the GALACO study].
Rodriguez-Osorio X; Lopez-Gonzalez FJ; Pato-Pato A; Cebrian-Perez E; Marey-Lopez J; Corredera-Garcia E; Rubio-Nazabal E; Castro-Vilanova MD; Abella-Corral J; Rodriguez-Regal A; Amigo-Jorrin MC; Pego-Reigosa R;
Rev Neurol; 2015 Dec; 61(12):536-42. PubMed ID: 26662871
[TBL] [Abstract][Full Text] [Related]
17. Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind study.
Wechsler RT; Li G; French J; O'Brien TJ; D'Cruz O; Williams P; Goodson R; Brock M;
Epilepsia; 2014 Jul; 55(7):1088-98. PubMed ID: 24915838
[TBL] [Abstract][Full Text] [Related]
18. [Lacosamide in the treatment of epilepsy].
Petrukhin AS; Voronkova KV; Pylaeva OA
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6 Pt 2):65-71. PubMed ID: 22983249
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy.
Yorns WR; Khurana DS; Carvalho KS; Hardison HH; Legido A; Valencia I
J Child Neurol; 2014 Jan; 29(1):23-7. PubMed ID: 23143718
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
